Regencell Bioscience Holdings Ltd financial data

Symbol
RGC on Nasdaq
Location
Hong Kong
Latest financial report
20-F - Q2 2025 - 31 Oct 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 494,488,908 shares 3700%
Common Stock, Shares, Outstanding 494,488,908 shares 0%
Common Stock, Value, Issued $4,945 USD 3704%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $4,902,813 USD -40%
Property, Plant and Equipment, Net $215,434 USD 52%
Operating Lease, Right-of-Use Asset $544,385 USD 542%
Assets $5,755,582 USD -32%
Accrued Liabilities, Current $348,354 USD 178%
Liabilities, Current $663,673 USD 243%
Operating Lease, Liability, Noncurrent $231,635 USD 793%
Liabilities $895,308 USD 308%
Accumulated Other Comprehensive Income (Loss), Net of Tax $64,786 USD -42%
Retained Earnings (Accumulated Deficit) $25,201,116 USD -17%
Stockholders' Equity Attributable to Parent $4,860,274 USD -41%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,860,274 USD -41%
Liabilities and Equity $5,755,582 USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 100,000,000,000 shares 0%
Common Stock, Shares, Issued 494,488,908 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,419,115 USD -18%
Deferred Tax Assets, Valuation Allowance $4,060,695 USD 17%
Operating Lease, Liability $544,415 USD 535%
Lessee, Operating Lease, Liability, to be Paid $574,346 USD 553%
Property, Plant and Equipment, Gross $1,072,701 USD 16%
Operating Lease, Liability, Current $312,780 USD 423%
Lessee, Operating Lease, Liability, to be Paid, Year Two $220,313 USD 777%
Lessee, Operating Lease, Liability, to be Paid, Year One $336,364 USD 436%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 19%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29,931 USD 1274%
Lessee, Operating Lease, Liability, to be Paid, Year Three $17,669 USD
Deferred Tax Assets, Operating Loss Carryforwards $3,338,878 USD 20%